Posted:
9/25/2025, 7:28:13 PM
Experience Level(s):
Senior
Field(s):
Software Engineering
Workplace Type:
Hybrid
Position Summary
Insulet Corporation, maker of the OmniPod, is the world leader of wearable tubeless insulin pumps. With the completion of development and anticipated commercial release of the Horizon automated insulin deliver system, Insulet continues to invest substantially in developing next generation technologies based on the OmniPod platform to reduce burden and improve therapy for diabetes patients. We are seeking a passionate researcher to advance the automated insulin delivery (AID) algorithm for next generation AID system which will greatly simplify patient-pump interactions while achieving better glycemic outcomes. This individual contributor will join the existing algorithm R&D team and be a technical leader primarily responsible for researching and developing robust glucose control algorithms that require little to no user intervention while meeting safe and effective treatment goals.
Responsibilities
Education And Experience
Preferred Skills And Competencies
Physical Requirements (if Applicable)
NOTE: This position is eligible for 100% remote working arrangements (may work from home/virtually 100%; may also work hybrid on-site/virtual as desired).
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
We are looking for highly motivated, performance-driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it!
Please read our Privacy Notice to learn how Insulet handles your personal information when you apply for a vacancy with us here.
Website: https://insulet.com/
Headquarter Location: Bedford, Massachusetts, United States
Employee Count: 501-1000
Year Founded: 2000
IPO Status: Private
Last Funding Type: Post-IPO Debt
Industries: Biotechnology ⋅ Diabetes ⋅ Health Care ⋅ Medical Device